-
NPS Focus: “Nitazene" Synthetic Opioids
Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes phenibut, tianeptine,…
-
Finding Fentanyl
Synthetic opioids, including fentanyl, buprenorphine, meperidine, methadone and others,1 comprise a class of drugs manufactured in laboratories designed…
-
Interpretation of Buprenorphine and Naloxone Results: Considerations for Dosage Form and Specimen Type
Buprenorphine prescribing is extremely common across multiple clinical specialties, primarily opioid use disorder (OUD) and pain management treatment providers. …
-
NPS Focus: Designer Benzodiazepines
Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes designer benzodiazepines,…
-
Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™
Aegis Sciences Corporation, a leading healthcare company that provides innovative medication adherence testing, is pleased to announce the expansion of…
-
Increase in Drug Overdoses Due to Synthetic Opioids During the COVID-19 Pandemic
The challenges of the COVID-19 pandemic have continued to affect populations across the world in numerous ways. Finding a solution to the pandemic has…
-
What Did My Patient Actually Take? An Overview of Dextromethorphan/Levorphanol Results
Accurate interpretation of dextromethorphan/levorphanol results should take into account the patient’s prescription and over-the-counter (OTC) drug regimen…
